Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹183.10
1.14 (0.62%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹640 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
21.8
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹117.25+56.2%
52W High₹250-26.8%
Current Price
₹183.10
Circuit Limits (5%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹173.95
Upper Circuit₹192.26
Reference Price
₹183.10
Investment Checklist
Ascending Channel on 1D — target ₹188.59
Rising Wedge on 1D — target ₹147.31
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Composite score 2.18 (NEUTRAL) with 72.0% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
72%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)
EMA20
186.47
EMA50
177.97
EMA200
175.97
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows5
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹184.10
₹186.95
₹191.85
₹197.00
₹203.00
Support (Below)
₹179.83
₹177.97
₹173.40
₹170.58
₹164.74
Volume Analysis
TrendDECREASING
Change-28.50%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹181.27
3% Risk₹177.61
5% Risk₹173.94
7% Risk (Custom)
₹170.28Technical Levels
1x ATR (Volatility)₹173.22
2x ATR (Swing)₹163.34
3x ATR (Trend)₹153.46
Immediate Support₹179.83
Moving Averages
EMA 50 (Trend)₹177.97
EMA 200 (Long-term)₹175.97
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹56.2 Cr | ₹60.1 Cr | ₹43.1 Cr | ₹48.9 Cr |
| Net Profit | ₹6 Cr | ₹10.8 Cr | ₹3 Cr | ₹8.2 Cr |
| EPS | ₹3.63 | — | ₹1.84 | ₹4.97 |
| Operating Profit | ₹10.5 Cr | ₹16.7 Cr | ₹5.8 Cr | ₹11.7 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Kilitch Drugs (India) Limited | ₹183.10 | -0.62% | 21.8 | ₹640 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 24 Mar 2026 | Bonus 1:1 | BONUS |
| 15 Jul 2025 | Rights 2:23 @ Premium Rs 347/- | RIGHTS_ISSUE |
| 19 Sept 2024 | Annual General Meeting | AGM |
| 21 Sept 2023 | Annual General Meeting | AGM |
| 20 Sept 2022 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
| Date | Purpose | Links |
|---|---|---|
| 15 May 2026 | Board Meeting Intimation | |
| 15 May 2026 | Financial Results | |
| 11 Feb 2026 | Bonus | |
| 11 Feb 2026 | Other business matters | |
| 11 Feb 2026 | Financial Results |
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for KILITCH
View All
neutral
Google News - India Markets 65d ago
Kilitch Drugs (India) Ltd. Schedules Board Meeting on May 15, 2026 to Approve Q4FY26 Financial Results - scanx.trade
Kilitch Drugs (India) Ltd. Schedules Board Meeting on May 15, 2026 to Approve Q4FY26 Financial Resultsscanx.trade
JMFINANCILKILITCHFinancial ServicesHealthcare